DY
GOSS icon

Dowling & Yahnke’s Gossamer Bio GOSS Stock Holding History

Dowling & Yahnke’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$181K Hold
15,100
– – 0.01% 354
2022
Q2 		$126K Hold
15,100
– – 0.01% 365
2022
Q1 		$131K Buy
+15,100
New +$146K 0.01% 366
2021
Q3 		– Sell
-95,575
Closed -$776K – 379
2021
Q2 		$776K Sell
95,575
-30,000
-24% -$260K 0.04% 229
2021
Q1 		$1.16M Buy
125,575
+25,000
+25% +$252K 0.08% 196
2020
Q4 		$973K Buy
100,575
+90,000
+851% +$887K 0.07% 203
2020
Q3 		$131K Buy
+10,575
New +$140K 0.01% 299

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Dowling & Yahnke's GOSS Position: Q3 2022 in Review

Dowling & Yahnke held its Gossamer Bio (GOSS) position steady in Q3 2022 at 15,100 shares worth $181K. The position accounts for 0.01% of the portfolio, ranked #354.

Dowling & Yahnke first reported a position in GOSS in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.16M in Q1 2021. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Dowling & Yahnke held 15,100 shares of Gossamer Bio worth $181K as of Q3 2022.
  • Dowling & Yahnke left its Gossamer Bio share count unchanged in Q3 2022.
  • Gossamer Bio made up 0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #354 holding.
  • Dowling & Yahnke first reported a position in Gossamer Bio in Q3 2020 and has held it in 7 quarters since.
  • Dowling & Yahnke's Gossamer Bio position peaked at $1.16M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.